Literature DB >> 12436204

The use of taurine analogues to investigate taurine functions and their potential therapeutic applications.

L Della Corte1, R R Crichton, G Duburs, K Nolan, K F Tipton, G Tirzitis, R J Ward.   

Abstract

Despite the multitude of evidence for the beneficial effects of taurine supplementation in a variety of disease, the underlying modifying action of taurine with respect to either molecular or biochemical mechanisms is almost totally unknown. We have assessed the development of taurine analogues, particularly where there has been substitution at the suphonate or amine group. Such substitutions allow the investigator to probe the relationship between structure and function of the taurine molecule. In addition such studies should help to ascertain taurine's point of interaction with the effector molecule. These results will prepare the way for the development of the second generation of taurine analogues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12436204     DOI: 10.1007/s00726-002-0210-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  9 in total

1.  Functional characteristics of TauA binding protein from TauABC Escherichia coli system.

Authors:  Cédric Javaux; Bernard Joris; Philippe De Witte
Journal:  Protein J       Date:  2007-06       Impact factor: 2.371

2.  Concentration of amino acid neurotransmitters in the somatosensory cortex of the rat after surgical or functional deafferentation.

Authors:  Marie-Hélène Canu; Nicolas Treffort; Florence Picquet; Guy Dubreucq; Yann Guerardel; Maurice Falempin
Journal:  Exp Brain Res       Date:  2006-03-17       Impact factor: 1.972

3.  Circadian and acamprosate modulation of elevated ethanol drinking in mPer2 clock gene mutant mice.

Authors:  Allison J Brager; Rebecca A Prosser; J David Glass
Journal:  Chronobiol Int       Date:  2011-10       Impact factor: 2.877

4.  In Vivo Sex-Dependent Effects of Perinatal Pb2+ Exposure on Pilocarpine-Induced Seizure Susceptibility and Taurine Neuropharmacology.

Authors:  Michelle A Vasquez; George B Cruz; Ericka Cabañas; Jewel N Joseph; Mohammad Mian; Sai Karthik V Madhira; Chelsea A Akintunde; Evan G Clarke; Jourvonn C Skeen; Jalen R Bonitto; Eric B Khairi; Kirsten P Lynch; Narmin H Mekawy; Abdeslem El Idrissi; Youngjoo Kim; Bright U Emenike; Lorenz S Neuwirth
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Taurine-Derived Compounds Produce Anxiolytic Effects in Rats Following Developmental Lead Exposure.

Authors:  Lorenz S Neuwirth; Bright U Emenike; George B Cruz; Ericka Cabañas; Michelle A Vasquez; Jewel N Joseph; Zaid Ayaz; Mohammed Mian; Mohamed M Ali; Evan G Clarke; Eddy D Barrera; Nimra Hameed; Samantha Rubi; Teddy F Dacius; Jourvonn C Skeen; Jalen R Bonitto; Eric B Khairi; Asma Iqbal; Isra Ahmed; Tokunbo J Jose; Kirsten P Lynch; Amber Alivira; Neena Mathew; Sukhpreet Kaur; Sidrah Masood; Bettina Tranquilee; Veni Thiruverkadu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Influences of Taurine Pharmacodynamics and Sex on Active Avoidance Learning and Memory.

Authors:  Wei Zhu; George B Cruz; Zaid Ayaz; Jewel N Joseph; Akil Boby; Patrick Cadet; Lorenz S Neuwirth
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

7.  Guanidinoacetate inhibits glutamate uptake in rat striatum of rats at different ages.

Authors:  Alexandra I Zugno; Diogo L Oliveira; Emilene B S Scherer; Moacir Wajner; Susana Wofchuk; Angela T S Wyse
Journal:  Neurochem Res       Date:  2007-02-02       Impact factor: 4.414

8.  Design, synthesis, cytotoxic activity, and apoptosis inducing effects of 4- and N-substituted benzoyltaurinamide derivatives.

Authors:  Özlem AkgÜl; Mümin Alper ErdoĞan; Derviş Bİrİm; Çağla KayabaŞi; Cumhur GÜndÜz; Güliz ArmaĞan
Journal:  Turk J Chem       Date:  2020-12-16       Impact factor: 1.239

9.  Differential modulation of human GABAC-ρ1 receptor by sulfur-containing compounds structurally related to taurine.

Authors:  Lenin David Ochoa-de la Paz; Martin González-Andrade; Herminia Pasantes-Morales; Rodrigo Franco; Rubén Zamora-Alvarado; Edgar Zenteno; Hugo Quiroz-Mercado; Roberto Gonzales-Salinas; Rosario Gulias-Cañizo
Journal:  BMC Neurosci       Date:  2018-08-03       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.